NCT03665792

Completed

The Correlation Between Sevoflurane and qNOX

China International Neuroscience Institution Source

Compare

Other study identifiers

Sponsor study identifier

CINI-ZYLX-201806-11

Study Type

observational

Actual enrollment (reported)

58

Locations

1 country

Sites

1

Timeline

Study Start

February 11, 2019

Actual (reported)

Primary Completion

September 1, 2019

Actual (reported)

Study Completion

September 1, 2019

Actual (reported)

Brief Summary

This study purpose to observation the sevoflurane analgesia effect, and using nociception real-time monitoring NOX to test the correlation between the sevoflurane and NOX index.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 58 participants
Study completion date: September 1, 2019
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

First Submitted
August 4, 2018
Actual (reported)
First Posted
September 11, 2018
Actual (reported)
Study Start
February 11, 2019
Actual (reported)
Primary Completion
September 1, 2019
Actual (reported)
Study Completion
September 1, 2019
Actual (reported)

Last Updated: January 22, 2020
Status Verified: January 2020
Last Update Submitted: January 20, 2020

Conditions

Analgesic Adverse Reaction Inhalation; Vapor Nociceptive Pain

Outcome Measures

Primary Outcomes (1)

The sevoflurane application correlated with the qNOX index
The sevoflurane application correlated with the qNOX index, meanwhile reflect the analgesia effect of sevoflurane application
through study completion, an average of 1 year

Interventions

nociception index qNOXDevice

non-invasive, real time, monitoring for nociception stimulation

Also known as: CON , BIS

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age25 Years - 85 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodProbability Sample

Study Population

only elective thoracoscope surgery patients were enrolled

You may qualify if:

Elective thoracoscope surgery patients

Sponsors & Collaborators

China International Neuroscience Institution
Otherlead

Study Sites (1)

Bei Liu

Beijing, Beijing Municipality, 100053, China

MeSH Terms

Conditions

Nociceptive PainRespiratory Aspiration

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsRespiration DisordersRespiratory Tract DiseasesPathologic Processes

Study Officials

Xiaohua Wang, MD,PHD
Xuanwu Hospital, Beijing
PRINCIPAL INVESTIGATOR

Enrollment

58 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: OTHER
Time Perspective: CROSS SECTIONAL
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

August 4, 2018

First Posted

September 11, 2018

Study Start

February 11, 2019

Actual (reported)

NCT03443518

Psoas Compartment Block (PCB) Versus L.A Infiltration and Remifentanil Infusion During EVAR

Phase 2Completed

NCT04305015

Postoperative Benefits of Intraoperative Nociception Level (NOL) Titration - Pilot

Not ApplicableCompleted

NCT03453541

Ketorolac Use in Pediatric Patients Undergoing Tonsillectomy

Phase 4Terminated

NCT04696016

Guiding Sufentanil Administration With Skin Conductance in Mechanically Ventilated Intensive Care Patients

Not ApplicableUnknown

NCT03556696

Automatic Remifentanil Administration Guided by ANI During Propofol Anesthesia

Not ApplicableCompleted

NCT03203967

Epidural Morphine for Postoperative Analgesia After Total Knee Arthroplasty

Not ApplicableCompleted

Age ranging from 25 to 85 years

American Society of Anesthesiologists (ASA) Physical Status score of 2 to 4

a body mass index (BMI) ranging from 18.5 to 40 kg/m2.

You may not qualify if:

Clinical diagnosis of Alzheimer's Disease
implanted pacemaker
Clinical diagnosis of psychiatric diseases
Clinical diagnosis of epilepsy
Clinical diagnosis of autonomic nervous system disorders which might affect the EEG

Contact the study team to confirm eligibility.

Primary Completion

September 1, 2019

Actual (reported)

Study Completion

September 1, 2019

Actual (reported)

Last Updated

January 22, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing: Will not share

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT03665792
Data provider: ClinicalTrials.gov
Source updated: 2020-01-22
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:40:24 UTC

Locations

CN(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations